Director, Global Market Access

The Director, Global Market Access leads global pricing and market access strategy for Alnylam’s Rare Disease portfolio and selected pipeline assets, ensuring consistent approaches to securing access for current and future products. The role involves analyzing business cases, supporting pricing decisions for Partner & Emerging Markets, and managing the Global Pricing System to drive efficiency and future-readiness. This position requires collaboration with cross-functional teams to develop strategic access plans, payer value stories, and innovative market access strategies.